Pharma Industry
Industry: Email Alert RSS FeedApplied Genetics News
View more issues: March 19, 1999, April 1999, June 1999
Articles in May 1999 issue of Applied Genetics News
- Cancer Gene Therapy Collaboration
- European Approval for Vitravene
- Antibodies Treat Psoriasis
- Rituxan Sales Reach $52 Million in 1Q
- Adenyl Cyclase for Heart Failure
- CELL THERAPY: Network of Cell Labs Planned
- VACCINES AND ANTI-INFECTIVES They're Back: TB, Herpes, Hepatitis, Chlamydia
- CALENDAR
- Gentronics Wins Electroporation Grant
- Transplanted Nerve Cells for Alzheimer's
- Microbial Proteins May Inhibit MS
- GENOMICS: Angiogenesis Polysaccharide Receptor Discovered
- Prostate Cancer Vaccine Promising
- Growth Control Protein Described
- Bone Marrow Reduces Rejection of Organs
- IND Filed for HIV Fusion Inhibitor
- BIOMANUFACTURING: Cloned Goats Make Antithrombin
- Genset Creates Genomics Department
- Cell Therapy for Heart Disease
- Membrane-Bound Cytokine Vaccine
- Stroke Genes Under Investigation
- Aastrom Awarded Two Patents
- GROWTH FACTORS: Regranex Approved in Europe
- Cancer Vaccine Facility Opened
- Prostate Cancer Genes Patented
- Apligraf Heals Foot Ulcers
- AG-BIO: Molecular Applications in Deal with Monsanto
- DNA Plasmid Production Scaled-Up
- ANTISENSE: Genta's G3139 in Anti-tumor Trials
- ANTIBODIES: Report of HIV Test Discordancies
- Pioneer Corn Hybrids Cleared by EU
- GENE THERAPY: Cancer Killing Virus Patented
- Antisense Compound Combats Restenosis
- Zenapax Reduces Organ Rejection
- INDUSTRY NEWS: Geron Acquires Roslin Bio-Med